TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Li, Yong Ju ^a   Wang, Chun Hong ^b   Zhou, Ya ^a   Liao, Zheng Yuan ^a   Zhu, Shun Fei ^a   Hu, Yan ^a   Chen, Chao ^a   Luo, Jun Min ^a   Wen, Zhen Ke ^c   Xu, Lin ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Qingdao Chest Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Human antigen R; Human lung cancer cell; miR 7; Toll like receptor 9

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIGEN; BROXURIDINE; CPG OLIGODEOXYNUCLEOTIDE; HUMAN ANTIGEN R; MICRORNA; MICRORNA 7; PROTEIN KINASE B INHIBITOR; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL ASSAY; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; EUKARYOTE; EXPRESSION VECTOR; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG CANCER; METASTASIS POTENTIAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

EID: 84883287264     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-90     Document Type: Article

References (31)

1. Pinto A, Morello S, Sorrentino R. Lung cancer and toll-like receptors. Cancer Immunol Immunother 2011, 60:1211-1220. 10.1007/s00262-011-1057-8, 21789594.
2. Droemann D, Albrecht D, Gerdes J, Ulmer AJ, Branscheid D, Vollmer E, Dalhoff K, Zabel P, Goldmann T. Human lung cancer cells express functionally active toll-like receptor 9. Respir Res 2005, 6:1. 10.1186/1465-9921-6-1, 544843, 15631627.
3. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL, Xu L. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell. Cancer Biol Ther 2007, 6:1704-1709. 10.4161/cbt.6.11.4826, 17986857.
4. Sorrentino R, Morello S, Giordano MG, Arra C, Maiolino P, Adcock IM, Pinto A. CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. Int J Cancer 2011, 128:2815-2822. 10.1002/ijc.25626, 20725994.
5. Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, Koutala E, Siafakas NM. Expression profiles of toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol 2012, 40:1397-1404.
6. Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang Y, Zhou Y, Zhou H, Wen Z. TLR9 Signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 2009, 15:623-630. 10.1007/s12253-009-9162-0, 19319670.
7. Xu L, Wang C, Wen Z, Yao X, Liu Z, Li Q, Wu Z, Xu Z, Liang Y, Ren T. Selective upregulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Immunol Lett 2010, 127:93-99. 10.1016/j.imlet.2009.10.002, 19854217.
8. Xu L, Zhou Y, Liu Q, Luo JM, Qing M, Tang XY, Yao XS, Wang CH, Wen ZK. CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Biochem Biophys Res Commun 2009, 382:571-576. 10.1016/j.bbrc.2009.03.072, 19302975.
9. Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Del Poeta G, Laurenti L, Efremov DG, Gattei V. The miR-17-92 family regulates the response to toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia 2012, 26:1584-1593. 10.1038/leu.2012.44, 22343732.
10. Li Q, Li X, Guo Z, Xu F, Xia J, Liu Z, Ren T. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PLoS One 2012, 7:e48278. 10.1371/journal.pone.0048278, 3487732, 23133627.
11. Rai K, Takigawa N, Ito S, Kashihara H, Ichihara E, Yasuda T, Shimizu K, Tanimoto M, Kiura K. Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells. Mol Cancer Ther 2011, 10:1720-1727. 10.1158/1535-7163.MCT-11-0220, 21712475.
12. Saydam O, Senol O, Würdinger T, Mizrak A, Ozdener GB, Stemmer-Rachamimov AO, Yi M, Stephens RM, Krichevsky AM, Saydam N, Brenner GJ, Breakefield XO. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res 2011, 71:852-861. 10.1158/0008-5472.CAN-10-1219, 3072568, 21156648.
13. Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK, Mo YY, Iiizumi-Gairani M, Hirota S, Liu Y, Wu K, Pochampally R, Watabe K. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 2013, 73:1434-1444. 10.1158/0008-5472.CAN-12-2037, 23384942.
14. Fang Y, Xue JL, Shen Q, et al. miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 2012, 55:1852-1862. 10.1002/hep.25576, 22234835.
15. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 2009, 284:5731-5741.
16. Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G, Luo J, Ren T. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. Mol Biol Cell 2013, 24:42-55. 10.1091/mbc.E12-07-0519, 3530778, 23135998.
17. Pineda DM, Rittenhouse DW, Valley CC, Cozzitorto JA, Burkhart RA, Leiby B, Winter JM, Weber MC, Londin ER, Rigoutsos I, Yeo CJ, Gorospe M, Witkiewicz AK, Sachs JN, Brody JR. HuR's Post-transcriptional regulation of death receptor 5 in pancreatic cancer cells. Cancer Biol Ther 2012, 13:946-955. 10.4161/cbt.20952, 3414415, 22785201.
18. Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, Kakuguchi W, Kuroshima T, Kondo M, Akino T, Totsuka Y, Shindoh M, Higashino F, Hida K. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br J Cancer 2011, 104:819-829. 10.1038/bjc.2011.20, 3048211, 21285980.
19. Serini S, Fasano E, Piccioni E, Monego G, Cittadini AR, Celleno L, Ranelletti FO, Calviello G. DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocation. Carcinogenesis 2012, 33:164-173. 10.1093/carcin/bgr240, 22045024.
20. Choudhury NR, de Lima AF, de Andrés-Aguayo L, Graf T, Cáceres JF, Rappsilber J, Michlewski G. Tissue-specific control of brain-enriched miR-7 biogenesis. Genes Dev 2013, 27:24-38. 10.1101/gad.199190.112, 3553281, 23307866.
21. Singh M, Martinez AR, Govindaraju S, Lee BS. HuR inhibits apoptosis by amplifying Akt signaling through a positive feedback loop. J Cell Physiol 2013, 228:182-189. 10.1002/jcp.24120, 22674407.
22. Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, García-Rodríguez JL, Embade N, Fernández-Ramos D, Martínez-López N, Gutiérrez-De Juan V, Arteta B, Caballeria J, Lu SC, Mato JM, Varela-Rey M, Martínez-Chantar ML. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology 2012, 56:1870-1882. 10.1002/hep.25828, 22576182.
23. Doller A, Akool E-S, Huwiler A, Müller R, Radeke HH, Pfeilschifter J, Eberhardt W J. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 2008, 28:2608-2625. 10.1128/MCB.01530-07, 2293108, 18285462.
24. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 2000, 28:76-83. 10.1002/1098-2744(200006)28:2<76::AID-MC3>3.0.CO;2-0, 10900464.
25. Kim GY, Lim SJ, Kim YW. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Mod Pathol 2011, 24:1336-1347. 10.1038/modpathol.2011.90, 21572400.
26. Kong D, Piao YS, Yamashita S, Oshima H, Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, Satou K, Ushijima T, Ishikawa TO, Oshima M. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 2012, 31:3949-3960. 10.1038/onc.2011.558, 22139078.
27. Reddy SD, Ohshiro K, Rayala SK, Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008, 68:8195-8200. 10.1158/0008-5472.CAN-08-2103, 3636563, 18922890.
28. Eberhardt W, Doller A, Pfeilschifter J. Regulation of the mRNA-binding protein HuR by posttranslational modification: spotlight on phosphorylation. Curr Protein Pept Sci 2012, 13:380-390. 10.2174/138920312801619439, 22708484.
29. Jeyaraj SC, Singh M, Ayupova DA, Govindaraju S, Lee BS. Transcriptional control of human antigen R by bone morphogenetic protein. J Biol Chem 2010, 285:4432-4440. 10.1074/jbc.M109.062216, 2836048, 20018854.
30. Mansfield KD, Keene JD. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res 2012, 40:2734-2746. 10.1093/nar/gkr1114, 3315332, 22139917.
31. Dai W, Zhang G, Makeyev EV. RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res 2012, 40:787-800. 10.1093/nar/gkr783, 3258158, 21948791.